▶ 調査レポート

非侵襲性出生前診断 (NIPT) の世界市場:Materni21、ハーモニー、パノラマ、ベリファイ、NIFTY

• 英文タイトル:Non-Invasive Prenatal Testing Market (Test Type - Materni21, Harmony, Panorama, Verifi, NIFTY; Application - Trisomy, Microdeletions Symptoms, Others (Including Sex Chromosomes Disorders); Technology - NGS, WGS; End use - Hospitals, Diagnostic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
• レポートコード:TPM-JL083
• 出版社/出版日:Transparency Market Research / 2019年5月23日
• レポート形態:英文、PDF、186ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥614,270 (USD5,795)▷ お問い合わせ
  Multi User¥932,270 (USD8,795)▷ お問い合わせ
  Global Site License¥1,250,270 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、非侵襲性出生前診断 (NIPT) の世界市場について調べ、非侵襲性出生前診断 (NIPT) の世界市場規模、市場動向、市場シェア、市場環境、市場予測、検査種類別(Materni21、ハーモニー、パノラマ、ベリファイ、NIFTY)分析、用途別(トリソミー、微小欠乏症症状、その他(性染色体異常を含む))分析、技術別(NGS、WGS)分析、関連企業情報などをまとめました。
・非侵襲性出生前診断 (NIPT) の市場概要
・非侵襲性出生前診断 (NIPT) の市場動向
・非侵襲性出生前診断 (NIPT) の世界市場規模・予測
・非侵襲性出生前診断 (NIPT) 市場:検査種類別(Materni21、ハーモニー、パノラマ、ベリファイ、NIFTY)
・非侵襲性出生前診断 (NIPT) 市場:用途別(トリソミー、微小欠乏症症状、その他(性染色体異常を含む))
・非侵襲性出生前診断 (NIPT) 市場:技術別(NGS、WGS)
・地域別分析(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)
・競争環境・関連企業分析

Global Non-Invasive Prenatal Testing Market: Overview

Non-invasive prenatal testing (NIPT) is a novel genetic screening method based on the analysis of cell-free fetal DNA in the maternal plasma.
The market for non-invasive prenatal testing is expanding significantly, worldwide, primarily due to increasing incidences of chromosomal aneuploidies among fetus, rising demand for early and non-invasive screening procedures, and rise in advanced maternal age (earlier 23 to 26 years has increased to 30 years).
The global non-invasive prenatal testing market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on test type, application, technology, end-user, and region.
A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market.
This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global non-invasive prenatal testing market.
Global Non-Invasive Prenatal Testing Market: Key Segments

Based on test type, the global non-invasive prenatal testing market has been classified into Materni21, Harmony, Panorama, Verifi, NIFTY, and others.
In terms of application, the global non-invasive prenatal testing market has been divided into Trisomy, Microdeletions symptoms, and others (sex chromosomes disorders).
Based on technology, the global non-invasive prenatal testing market has been classified into NGS (next generation sequencing), WGS (whole genome sequencing), and others.
In terms of end user, the global non-invasive prenatal testing market has been split into hospitals, diagnostic laboratories, and others.
The market size and forecast for each of these segments have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year.
Global Non-Invasive Prenatal Testing Market: Regional Outlook

In terms of region, the global non-invasive prenatal testing market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Malaysia, Thailand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa and GCC Countries).
The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year. The research study also covers the competitive scenario in these regions.
Companies Mentioned in Report

The report also profiles the major players in the market in terms of attributes such as company overview, financial overview, Test Type, business strategies, and recent developments.
Major companies profiled in the global market are
Berry Genetics
BGI
Laboratory Corporation of America Holdings
Agilent Technologies, Inc.
Illumina, Inc
F. Hoffmann-La Roche Ltd
NATERA, INC.
PerkinElmer Inc
Eurofins LifeCodexx AG
IGENOMIX.
The global non-invasive prenatal testing market has been segmented as follows:

Global Non-Invasive Prenatal Testing Market, by Test Type

Materni21
Harmony
Panorama
Verifi
NIFTY
Others
Global Non-Invasive Prenatal Testing Market, by Application

Trisomy
Microdeletions Symptoms
Others (Including Sex Chromosomes Disorders)
Global Non-Invasive Prenatal Testing Market, by Technology

NGS
WGS
Others
Global Non-Invasive Prenatal Testing Market, by End-user

Hospitals
Diagnostic Laboratories
Others
Global Non-Invasive Prenatal Testing Market, by Region

North America
U.S.
Canada
Europe
Germany
U,K.
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
Thailand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Rest of Middle East & Africa

レポート目次

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Assumptions and Acronyms Used

2. Research Methodology

3. Executive Summary

4. Market Overview
4.1. Test Type Definition
4.2. Key Industry Evolution/Developments
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Increasing cases of Down’s Syndrome
4.3.1.2. Rising maternal age
4.3.1.3. Increasing demand for early and non-invasive fetal testing procedures
4.3.2. Restraints
4.3.2.1. Regulatory guidelines
4.3.2.2. Limitations of NIPT
4.3.2.3. Other alternatives
4.3.3. Opportunities
4.3.3.1. Emerging markets in Asia Pacific
4.4. Global Non-Invasive Prenatal Testing Market Analysis and Forecast, 2017–2027
4.5. Porter’s Five Forces Analysis

5. Market Outlook
5.1. Cost Comparison Analysis
5.2. Key Mergers & Acquisitions
5.3. Technological Advancements

6. Global Non-Invasive Prenatal Testing Market, by Test Type
6.1. Key Findings
6.2. Global Non-Invasive Prenatal Testing Market Value Share, by Test Type, 2019 and 2027
6.2.1. Materni21
6.2.2. Harmony
6.2.3. Panorama
6.2.4. Verifi
6.2.5. NIFTY
6.2.6. Others
6.3. Global Non-Invasive Prenatal Testing Market Attractiveness, by Test Type, 2019–2027
6.4. Global Non-Invasive Prenatal Testing Market Analysis, Y-o-Y Growth, by Test Type
6.5. Global Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

7. Global Non-Invasive Prenatal Testing Market, by Application
7.1. Key Findings
7.2. Global Non-Invasive Prenatal Testing Market Value Share, by Application, 2018 and 2027
7.2.1. Trisomy
7.2.2. Microdeletions Symptoms
7.2.3. Others (Including Sex Chromosomes Disorders)
7.3. Global Non-Invasive Prenatal Testing Market Attractiveness, by Application, 2019–2027
7.4. Global Non-Invasive Prenatal Testing Market Analysis, Y-o-Y Growth, by Application
7.5. Global Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Application, 2017–2027

8. Global Non-Invasive Prenatal Testing Market, by Technology
8.1. Key Findings
8.2. Global Non-Invasive Prenatal Testing Market Value Share, by Technology, 2018 and 2027
8.2.1. NGS
8.2.2. WGS
8.2.3. Others
8.3. Global Non-Invasive Prenatal Testing Market Attractiveness, by Technology, 2019–2027
8.4. Global Non-Invasive Prenatal Testing Market Analysis, Y-o-Y Growth, by Technology
8.5. Global Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Technology, 2017–2027

9. Global Non-Invasive Prenatal Testing Market, by End-user
9.1. Key Findings
9.2. Global Non-Invasive Prenatal Testing Market Value Share, by End-user, 2018 and 2027
9.2.1. Hospitals
9.2.2. Diagnostic Laboratories
9.2.3. Others
9.3. Global Non-Invasive Prenatal Testing Market Attractiveness, by End-user, 2019–2027
9.4. Global Non-Invasive Prenatal Testing Market Analysis, Y-o-Y Growth, by End-user
9.5. Global Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

10. Global Non-Invasive Prenatal Testing Market, by Region
10.1. Key Findings
10.2. Global Non-Invasive Prenatal Testing Market Value Share, by Region, 2018 and 2027
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Non-Invasive Prenatal Testing Market Attractiveness, by Region, 2019–2027
10.4. Global Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Region, 2017–2027

11. North America Non-Invasive Prenatal Testing Market Analysis and Forecast, 2019–2027
11.1. Key Findings
11.2. North America Non-Invasive Prenatal Testing Market Value Share, by Test Type, 2018 and 2027
11.2.1. Materni21
11.2.2. Harmony
11.2.3. Panorama
11.2.4. Verifi
11.2.5. NIFTY
11.2.6. Others
11.3. North America Non-Invasive Prenatal Testing Market Attractiveness, by Test Type, 2019–2027
11.4. North America Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
11.5. North America Non-Invasive Prenatal Testing Market, by Application
11.6. Key Findings
11.7. North America Non-Invasive Prenatal Testing Market Value Share, by Application, 2018 and 2027
11.7.1. Trisomy
11.7.2. Microdeletions Symptoms
11.7.3. Others (Including Sex Chromosomes Disorders)
11.8. North America Non-Invasive Prenatal Testing Market Attractiveness, by Application, 2019–2027
11.9. North America Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Application, 2017–2027
11.10. North America Non-Invasive Prenatal Testing Market, by Technology
11.11. Key Findings
11.12. North America Non-Invasive Prenatal Testing Market Value Share, by Technology, 2018 and 2027
11.12.1. NGS
11.12.2. WGS
11.12.3. Others
11.13. North America Non-Invasive Prenatal Testing Market Attractiveness, by Technology, 2019–2027
11.14. North America Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Technology, 2017–2027
11.15. North America Non-Invasive Prenatal Testing Market, by End-user
11.16. Key Findings
11.17. North America Non-Invasive Prenatal Testing Market Value Share, by End-user, 2018 and 2027
11.17.1. Hospitals
11.17.2. Diagnostic Laboratories
11.17.3. Others
11.18. North America Non-Invasive Prenatal Testing Market Attractiveness, by End-user, 2019–2027
11.19. North America Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
11.20. North America Non-Invasive Prenatal Testing Market, by Country
11.21. Key Findings
11.22. North America Non-Invasive Prenatal Testing Market Value Share, by Country, 2018 and 2027
11.22.1. U.S.
11.22.2. Canada
11.23. North America Non-Invasive Prenatal Testing Market Attractiveness, by Country, 2019–2027
11.24. North America Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Country, 2017–2027

12. Europe Non-Invasive Prenatal Testing Market Analysis and Forecast, 2019–2027
12.1. Key Findings
12.2. Europe Non-Invasive Prenatal Testing Market Value Share, by Test Type, 2018 and 2027
12.2.1. Materni21
12.2.2. Harmony
12.2.3. Panorama
12.2.4. Verifi
12.2.5. NIFTY
12.2.6. Others
12.3. Europe Non-Invasive Prenatal Testing Market Attractiveness, by Test Type, 2019–2027
12.4. Europe Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
12.5. Europe Non-Invasive Prenatal Testing Market, by Application
12.6. Key Findings
12.7. Europe Non-Invasive Prenatal Testing Market Value Share, by Application, 2018 and 2027
12.7.1. Trisomy
12.7.2. Microdeletions Symptoms
12.7.3. Others (Including Sex Chromosomes Disorders)
12.8. Europe Non-Invasive Prenatal Testing Market Attractiveness, by Application, 2019–2027
12.9. Europe Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Application, 2017–2027
12.10. Europe Non-Invasive Prenatal Testing Market, by Technology
12.11. Key Findings
12.12. Europe Non-Invasive Prenatal Testing Market Value Share, by Technology, 2018 and 2027
12.12.1. NGS
12.12.2. WGS
12.12.3. Others
12.13. Europe Non-Invasive Prenatal Testing Market Attractiveness, by Technology, 2019–2027
12.14. Europe Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Technology, 2017–2027
12.15. Europe Non-Invasive Prenatal Testing Market, by End-user
12.16. Key Findings
12.17. Europe Non-Invasive Prenatal Testing Market Value Share, by End-user, 2018 and 2027
12.17.1. Hospitals
12.17.2. Diagnostic Laboratories
12.17.3. Others
12.18. Europe Non-Invasive Prenatal Testing Market Attractiveness, by End-user, 2019–2027
12.19. Europe Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
12.20. Europe Non-Invasive Prenatal Testing Market, by Country
12.21. Key Findings
12.22. Europe Non-Invasive Prenatal Testing Market Value Share, by Country/Sub-region, 2018 and 2027
12.22.1. Germany
12.22.2. France
12.22.3. U.K.
12.22.4. Spain
12.22.5. Italy
12.22.6. Rest of Europe
12.23. Europe Non-Invasive Prenatal Testing Market Attractiveness, by Country/Sub-region, 2019–2027
12.24. Europe Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

13. Asia Pacific Non-Invasive Prenatal Testing Market Analysis and Forecast, 2019–2027
13.1. Key Findings
13.2. Asia Pacific Non-Invasive Prenatal Testing Market Value Share, by Test Type, 2018 and 2027
13.3. Non-Invasive Prenatal Testing Market Value Share, by Test Type, 2018 and 2027
13.3.1. Materni21
13.3.2. Harmony
13.3.3. Panorama
13.3.4. Verifi
13.3.5. NIFTY
13.3.6. Others
13.4. Asia Pacific Non-Invasive Prenatal Testing Market Attractiveness, by Test Type, 2019–2027
13.5. Asia Pacific Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
13.6. Asia Pacific Non-Invasive Prenatal Testing Market, by Application
13.7. Key Findings
13.8. Asia Pacific Non-Invasive Prenatal Testing Market Value Share, by Application, 2018 and 2027
13.8.1. Trisomy
13.8.2. Microdeletions Symptoms
13.8.3. Others (Including Sex Chromosomes Disorders)
13.9. Asia Pacific Non-Invasive Prenatal Testing Market Attractiveness, by Application, 2019–2027
13.10. Asia Pacific Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Application, 2017–2027
13.11. Asia Pacific Non-Invasive Prenatal Testing Market, by Technology
13.12. Key Findings
13.13. Asia Pacific Non-Invasive Prenatal Testing Market Value Share, by Technology, 2018 and 2027
13.13.1. NGS
13.13.2. WGS
13.13.3. Others
13.14. Asia Pacific Non-Invasive Prenatal Testing Market Attractiveness, by Technology, 2019–2027
13.15. Asia Pacific Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Technology, 2017–2027
13.16. Asia Pacific Non-Invasive Prenatal Testing Market, by End-user
13.17. Key Findings
13.18. Asia Pacific Non-Invasive Prenatal Testing Market Value Share, by End-user, 2018 and 2027
13.18.1. Hospitals
13.18.2. Diagnostic Laboratories
13.18.3. Others
13.19. Asia Pacific Non-Invasive Prenatal Testing Market Attractiveness, by End-user, 2019–2027
13.20. Asia Pacific Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
13.21. Asia Pacific Non-Invasive Prenatal Testing Market, by Country
13.22. Key Findings
13.23. Asia Pacific Non-Invasive Prenatal Testing Market Value Share, by Country/Sub-region, 2018 and 2027
13.23.1. China
13.23.2. Japan
13.23.3. India
13.23.4. Malaysia
13.23.5. Thailand
13.23.6. Rest of Asia Pacific
13.24. Asia Pacific Non-Invasive Prenatal Testing Market Attractiveness, by Country/Sub-region, 2019–2027
13.25. Asia Pacific Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

14. Latin America Non-Invasive Prenatal Testing Market Analysis and Forecast, 2019–2027
14.1. Key Findings
14.2. Latin America Non-Invasive Prenatal Testing Market Value Share, by Test Type, 2018 and 2027
14.2.1. Materni21
14.2.2. Harmony
14.2.3. Panorama
14.2.4. Verifi
14.2.5. NIFTY
14.2.6. Others
14.3. Latin America Non-Invasive Prenatal Testing Market Attractiveness, by Test Type, 2019–2027
14.4. Latin America Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
14.5. Latin America Non-Invasive Prenatal Testing Market, by Application
14.6. Key Findings
14.7. Latin America Non-Invasive Prenatal Testing Market Value Share, by Application, 2018 and 2027
14.7.1. Trisomy
14.7.2. Microdeletions Symptoms
14.7.3. Others (Including Sex Chromosomes Disorders)
14.8. Latin America Non-Invasive Prenatal Testing Market Attractiveness, by Application, 2019–2027
14.9. Latin America Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Application, 2017–2027
14.10. Latin America Non-Invasive Prenatal Testing Market, by Technology
14.11. Key Findings
14.12. Latin America Non-Invasive Prenatal Testing Market Value Share, by Technology, 2018 and 2027
14.12.1. NGS
14.12.2. WGS
14.12.3. Others
14.13. Latin America Non-Invasive Prenatal Testing Market Attractiveness, by Technology, 2019–2027
14.14. Latin America Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Technology, 2017–2027
14.15. Latin America Non-Invasive Prenatal Testing Market, by End-user
14.16. Key Findings
14.17. Latin America Non-Invasive Prenatal Testing Market Value Share, by End-user, 2018 and 2027
14.17.1. Hospitals
14.17.2. Diagnostic Laboratories
14.17.3. Others
14.18. Latin America Non-Invasive Prenatal Testing Market Attractiveness, by End-user, 2019–2027
14.19. Latin America Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
14.20. Latin America Non-Invasive Prenatal Testing Market, by Country
14.21. Key Findings
14.22. Latin America Non-Invasive Prenatal Testing Market Value Share, by Country/Sub-region, 2018 and 2027
14.22.1. Brazil
14.22.2. Mexico
14.22.3. Rest of Latin America
14.23. Latin America Non-Invasive Prenatal Testing Market Attractiveness, by Country/Sub-region, 2019–2027
14.24. Latin America Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

15. Middle East & Africa Non-Invasive Prenatal Testing Market Analysis and Forecast, 2019–2027
15.1. Key Findings
15.2. Middle East & Africa Non-Invasive Prenatal Testing Market Value Share, by Test Type, 2018 and 2027
15.2.1. Materni21
15.2.2. Harmony
15.2.3. Panorama
15.2.4. Verifi
15.2.5. NIFTY
15.2.6. Others
15.3. Middle East & Africa Non-Invasive Prenatal Testing Market Attractiveness, by Test Type, 2019–2027
15.4. Middle East & Africa Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
15.5. Middle East & Africa Non-Invasive Prenatal Testing Market, by Application
15.6. Key Findings
15.7. Middle East & Africa Non-Invasive Prenatal Testing Market Value Share, by Application, 2018 and 2027
15.7.1. Trisomy
15.7.2. Microdeletions Symptoms
15.7.3. Others (Including Sex Chromosomes Disorders)
15.8. Middle East & Africa Non-Invasive Prenatal Testing Market Attractiveness, by Application, 2019–2027
15.9. Middle East & Africa Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Application, 2017–2027
15.10. Middle East & Africa Non-Invasive Prenatal Testing Market, by Technology
15.11. Key Findings
15.12. Middle East & Africa Non-Invasive Prenatal Testing Market Value Share, by Technology, 2018 and 2027
15.12.1. NGS
15.12.2. WGS
15.12.3. Others
15.13. Middle East & Africa Non-Invasive Prenatal Testing Market Attractiveness, by Technology, 2019–2027
15.14. Middle East & Africa Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Technology, 2017–2027
15.15. Middle East & Africa Non-Invasive Prenatal Testing Market, by End-user
15.16. Key Findings
15.17. Middle East & Africa Non-Invasive Prenatal Testing Market Value Share, by End-user, 2018 and 2027
15.17.1. Hospitals
15.17.2. Diagnostic Laboratories
15.17.3. Others
15.18. Middle East & Africa Non-Invasive Prenatal Testing Market Attractiveness, by End-user, 2019–2027
15.19. Middle East & Africa Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
15.20. Middle East & Africa Non-Invasive Prenatal Testing Market, by Country
15.21. Key Findings
15.22. Middle East & Africa Non-Invasive Prenatal Testing Market Value Share, by Country, 2018 and 2027
15.22.1. South Africa
15.22.2. GCC
15.22.3. Rest of Middle East & Africa
15.23. Middle East & Africa Non-Invasive Prenatal Testing Market Attractiveness, by Country/Sub-region, 2019–2027
15.24. Middle East & Africa Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

16. Market Player – Competition Matrix
16.1. Market Share Analysis, by Company
16.2. Market Footprint Analysis
16.3. Company Profiles
16.3.1. Berry Genetics
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Financial Overview
16.3.1.3. Test Type Portfolio
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. BGI
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Financial Overview
16.3.2.3. Test Type Portfolio
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. F. Hoffmann-La Roche Ltd
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Financial Overview
16.3.3.3. Test Type Portfolio
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Laboratory Corporation of America Holdings
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Financial Overview
16.3.4.3. Test Type Portfolio
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Kaiser Optical Systems, Inc
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Financial Overview
16.3.5.3. Test Type Portfolio
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Agilent Technologies, Inc
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Financial Overview
16.3.6.3. Test Type Portfolio
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Illumina, Inc
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Financial Overview
16.3.7.3. Test Type Portfolio
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. NATERA, INC.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Financial Overview
16.3.8.3. Test Type Portfolio
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. PerkinElmer Inc
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Financial Overview
16.3.9.3. Test Type Portfolio
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Eurofins LifeCodexx AG
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Financial Overview
16.3.10.3. Test Type Portfolio
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. IGENOMIX
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Financial Overview
16.3.11.3. Test Type Portfolio
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview

List of Tables

Table 1 Cost Comparison Analysis
Table 2 Key Mergers & Acquisitions
Table 3 Technological Advancements
Table 4 Global Non-Invasive Prenatal Testing Market Value (US$ Mn) Forecast, 2019?2027
Table 5 Global Non-Invasive Prenatal Testing Market Analysis and Forecast, by Test Type
Table 6 Global Non-Invasive Prenatal Testing Market Analysis and Forecast, by Application
Table 7 Global Non-Invasive Prenatal Testing Market Analysis and Forecast, by Technology
Table 8 Global Non-Invasive Prenatal Testing Market Analysis and Forecast, by End-user
Table 9 Global Non-Invasive Prenatal Testing Market Analysis and Forecast, by Region
Table 10 North America Non-Invasive Prenatal Testing Market Analysis and Forecast, by Test Type
Table 11 North America Non-Invasive Prenatal Testing Market Analysis and Forecast, by Application
Table 12 North America Non-Invasive Prenatal Testing Market Analysis and Forecast, by Technology
Table 13 North America Non-Invasive Prenatal Testing Market Analysis and Forecast, by End-user
Table 14 North America Non-Invasive Prenatal Testing Market Analysis and Forecast, by Country
Table 15 Europe Non-Invasive Prenatal Testing Market Analysis and Forecast, by Test Type
Table 16 Europe Non-Invasive Prenatal Testing Market Analysis and Forecast, by Application
Table 17 Europe Non-Invasive Prenatal Testing Market Analysis and Forecast, by Technology
Table 18 Europe Non-Invasive Prenatal Testing Market Analysis and Forecast, by End-user
Table 19 Europe Non-Invasive Prenatal Testing Market Analysis and Forecast, by Country/Sub-region
Table 20 Asia Pacific Non-Invasive Prenatal Testing Market Analysis and Forecast, by Test Type
Table 21 Asia Pacific Non-Invasive Prenatal Testing Market Analysis and Forecast, by Application
Table 22 Asia Pacific Non-Invasive Prenatal Testing Market Analysis and Forecast, by Technology
Table 23 Asia Pacific Non-Invasive Prenatal Testing Market Analysis and Forecast, by End-user
Table 24 Asia Pacific Non-Invasive Prenatal Testing Market Analysis and Forecast, by Country/Sub-region
Table 25 Latin America Non-Invasive Prenatal Testing Market Analysis and Forecast, by Test Type
Table 26 Latin America Non-Invasive Prenatal Testing Market Analysis and Forecast, by Application
Table 27 Latin America Non-Invasive Prenatal Testing Market Analysis and Forecast, by Technology
Table 28 Latin America Non-Invasive Prenatal Testing Market Analysis and Forecast, by End-user
Table 29 Latin America Non-Invasive Prenatal Testing Market Analysis and Forecast, by Country/Sub-region
Table 30 Middle East & Africa Non-Invasive Prenatal Testing Market Analysis and Forecast, by Test Type
Table 31 Middle East & Africa Non-Invasive Prenatal Testing Market Analysis and Forecast, by Application
Table 32 Middle East & Africa Non-Invasive Prenatal Testing Market Analysis and Forecast, by Technology
Table 33 Middle East & Africa Non-Invasive Prenatal Testing Market Analysis and Forecast, by End-user
Table 34 Middle East & Africa Non-Invasive Prenatal Testing Market Analysis and Forecast, by Country/Sub-region


• 英文レポート名:Non-Invasive Prenatal Testing Market (Test Type - Materni21, Harmony, Panorama, Verifi, NIFTY; Application - Trisomy, Microdeletions Symptoms, Others (Including Sex Chromosomes Disorders); Technology - NGS, WGS; End use - Hospitals, Diagnostic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
• 日本語訳:非侵襲性出生前診断 (NIPT) の世界市場:Materni21、ハーモニー、パノラマ、ベリファイ、NIFTY
• レポートコード:TPM-JL083お問い合わせ(見積依頼・ご注文・質問)